George Golumbeski - 05 May 2022 Form 4 Insider Report for Sage Therapeutics, Inc. (SAGE)

Role: Director
Signature: /s/ Jennifer Fitzpatrick, as Attorney-in-Fact for George Golumbeski
Issuer symbol: SAGE
Transactions as of: 05 May 2022
Net transactions value: +$251,563
Form type: 4
Filing time: 09 May 2022, 09:32:30 UTC
Previous filing: 27 Apr 2022
Next filing: 10 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SAGE	Common Stock	Purchase	$251,563	+8,000		$31.45	8,000	05 May 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was executed in multiple trades at prices ranging from $31.33 USD to $31.50 USD. The price reported above reflects the weighted average sale price. The issuer hereby undertakes to provide, upon request, to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.